PERSPECTA

News from every angle

← Back to headlines

Nurix Stock Is Down 6% This Past Year, but One Biotech Fund Still Boosted Its Bet By $63 Million

22 Feb, 18:32 — 22 Feb, 18:32
PostShare
Only 1 source covers this story